Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease.

Abstract:

:Graft-versus-host disease (GVHD) is the main complication of allogeneic stem cell transplantation. However, diagnosis of GVHD and evaluation of response to immunosuppressive treatment is sometimes difficult. Since apoptosis is the histopathologic hallmark in GVHD, we investigated whether active GVHD-induced target organ destruction is mirrored by serum levels of the caspase-cleaved neo-epitope of cytokeratin-18 fragments (CK18Fs). Serum CK18F kinetics was monitored by M30 antibody-based enzyme-linked immunosorbent assay (ELISA) in 50 patients who fulfilled histopathologic and/or clinical criteria diagnostic for GVHD. Both intestinal and hepatic GVHD were consistently associated with significant elevations of CK18F levels over baseline. Responses of GVHD to immunosuppressive therapy were paralleled by CK18F decreases, whereas resistant GVHD was characterized by persistent CK18F rises. Clinical conditions that might represent relevant differential diagnoses, such as toxic mucositis, noncomplicated, infection-related diarrhea, and veno-occlusive disease were not associated with CK18F elevations. In conclusion, CK18F monitoring provides a serum marker for quantitative assessment of GVHD-associated apoptotic activity in intestinal and hepatic GVHD. Although apoptosis is not GVHD-specific, CK18Fs may help to distinguish active GVHD from GVHD-unrelated conditions with similar symptoms, and to monitor response to immunosuppressive treatment. Prospective studies are warranted to evaluate how CK18Fs may assist in the diagnosis, grading, and treatment guidance of GVHD.

journal_name

Blood

journal_title

Blood

authors

Luft T,Conzelmann M,Benner A,Rieger M,Hess M,Strohhaecker U,Görner M,Hegenbart U,Ho AD,Dreger P

doi

10.1182/blood-2006-10-049817

subject

Has Abstract

pub_date

2007-12-15 00:00:00

pages

4535-42

issue

13

eissn

0006-4971

issn

1528-0020

pii

blood-2006-10-049817

journal_volume

110

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?

    abstract::The present study in patients with aplastic anemia was undertaken to determine whether exposure of recipients to donor blood products 24 hr before preparation with cyclophosphamide (1) enhanced the rate of sustained engraftment of marrow from HLA-identical siblings as suggested by animal experiments, (2) increased the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Storb R,Prentice RL,Banaji M,Witherspoon RP,Sullivan KM,Stewart P,Sanders JE,Mason M,Doney K,Deeg J,Clift RA,Buckner CD,Appelbaum FR,Thomas ED

    更新日期:1983-04-01 00:00:00

  • Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.

    abstract::In utero hematopoietic stem cell transplantation (IUHSCTx) can achieve mixed hematopoietic chimerism and donor-specific tolerance without cytoreductive conditioning or immunosuppression. The primary limitation to the clinical application of IUHSCTx has been minimal donor cell engraftment, well below therapeutic levels...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0016

    authors: Hayashi S,Peranteau WH,Shaaban AF,Flake AW

    更新日期:2002-08-01 00:00:00

  • All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

    abstract::We previously reported a benefit for all-trans retinoic acid (ATRA) in both induction and maintenance therapy in patients with acute promyelocytic leukemia (APL). To determine the durability of this benefit and identify important prognostic factors, long-term follow-up of the North American Intergroup APL trial is rep...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2002-02-0632

    authors: Tallman MS,Andersen JW,Schiffer CA,Appelbaum FR,Feusner JH,Woods WG,Ogden A,Weinstein H,Shepherd L,Willman C,Bloomfield CD,Rowe JM,Wiernik PH

    更新日期:2002-12-15 00:00:00

  • Fetal liver cells produce both fetal and adult erythrocytes in semiallogeneic radiation chimeras: possible influence of adult environment.

    abstract::Two kinds of erythrocytes are released in the blood of irradiated adult hybrid mice grafted with parental fetal liver cells: fetal antigen-bearing erythrocytes (Ft+ cells) and adult-type Ft- erythrocytes. Both are of parental origin, as determined by immune lysis using histocompatibility alloantigens. The latter cells...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mouchiroud G,Blanchet JP

    更新日期:1981-03-01 00:00:00

  • Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.

    abstract::We recently identified aberrant cytoplasmic expression of nucleophosmin (NPM) as the immunohistochemical marker of a large subgroup of acute myeloid leukemia (AML) (about one-third of adult AML) that is characterized by normal karyotype and mutations occurring at the exon-12 of the NPM gene. In this paper, we have elu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-11-4745

    authors: Falini B,Bolli N,Shan J,Martelli MP,Liso A,Pucciarini A,Bigerna B,Pasqualucci L,Mannucci R,Rosati R,Gorello P,Diverio D,Roti G,Tiacci E,Cazzaniga G,Biondi A,Schnittger S,Haferlach T,Hiddemann W,Martelli MF,Gu W,

    更新日期:2006-06-01 00:00:00

  • Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.

    abstract::The extended use of brentuximab-vedotin was reported for CD30(+) nonanaplastic peripheral T-cell lymphomas (PTCLs) with promising efficacy. CD30 status assessment is thus a critical factor for therapeutic decision, but the reliability of immunohistochemistry (IHC) in evaluating its expression remains to be defined. Th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-584953

    authors: Bossard C,Dobay MP,Parrens M,Lamant L,Missiaglia E,Haioun C,Martin A,Fabiani B,Delarue R,Tournilhac O,Delorenzi M,Gaulard P,de Leval L

    更新日期:2014-11-06 00:00:00

  • To be, or not to be, an eosinophil: that is the ???

    abstract::In this issue of Blood, Doyle et al provide evidence that knockout of the genes encoding the two most abundant eosinophil secondary granule proteins disrupts the normal differentiation of eosinophils from progenitors in the bone marrow, providing a novel strain of mice with a highly specific deficiency in eosinophilop...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2013-06-508507

    authors: Ackerman SJ

    更新日期:2013-08-01 00:00:00

  • Biotherapy for xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin.

    abstract::The study of central nervous system (CNS) leukemia has been hampered by the lack of a suitable animal model. We report that severe combined immunodeficiency (SCID) mice invariably develop rapidly progressive fatal CNS leukemia within 3 weeks after intravenous injection of NALM-6 pre-B acute lymphoblastic leukemia (ALL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gunther R,Chelstrom LM,Tuel-Ahlgren L,Simon J,Myers DE,Uckun FM

    更新日期:1995-05-01 00:00:00

  • Critical role of class IA PI3K for c-Rel expression in B lymphocytes.

    abstract::The fact that the Xid mutation of Btk impairs the ability of pleckstrin homology domain of Btk to bind phosphatidylinositol-(3,4,5)-trisphosphate, a product of class IA phosphoinositide-3 kinases (PI3Ks), has been considered strong evidence for the hypothesis that Btk functions downstream of PI3Ks. We demonstrate here...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-163725

    authors: Matsuda S,Mikami Y,Ohtani M,Fujiwara M,Hirata Y,Minowa A,Terauchi Y,Kadowaki T,Koyasu S

    更新日期:2009-01-29 00:00:00

  • Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts.

    abstract::We have examined the in vitro effects of recombinant human (rh) interleukin-1 (IL-1) on the growth of purified megakaryoblasts obtained from patients with acute megakaryoblastic leukemia. We demonstrate that both IL-1 alpha and IL-1 beta treatment of these cells led to stimulation of DNA synthesis (as shown by increas...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brach MA,Löwenberg B,Mantovani L,Schwulera U,Mertelsmann R,Herrmann F

    更新日期:1990-11-15 00:00:00

  • Approach to the treatment of multiple myeloma: a clash of philosophies.

    abstract::In this Perspective, we summarize some of the most contentious issues surrounding diagnosis and treatment of myeloma. We outline how a fundamental clash of philosophies, cure versus control, may be at the heart of many of the controversies. From the very definition of the disease to risk stratification to the validity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-297853

    authors: Rajkumar SV,Gahrton G,Bergsagel PL

    更新日期:2011-09-22 00:00:00

  • Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms.

    abstract::The Bcl-2 proto-oncogene was discovered at the t(14;18) breakpoint found in most follicular B-cell lymphomas and some diffuse large-cell lymphomas. Bcl-2 is unique among proto-oncogenes, being localized to mitochondria and extending cell survival by blocking programmed cell death. We examined Bcl-2 protein expression ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zutter M,Hockenbery D,Silverman GA,Korsmeyer SJ

    更新日期:1991-08-15 00:00:00

  • Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure.

    abstract::In a phase I/II study, 19 patients with advanced tumors but normal hematopoiesis and nine patients with bone marrow failure and prolonged severe cytopenias were treated with recombinant human interleukin-3 (rhIL-3) to assess the toxicity and biological effects of this multipotential hematopoietic growth factor. Doses ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ganser A,Lindemann A,Seipelt G,Ottmann OG,Herrmann F,Eder M,Frisch J,Schulz G,Mertelsmann R,Hoelzer D

    更新日期:1990-08-15 00:00:00

  • High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.

    abstract::Thrombopoietin (TPO) is a hematopoietic growth factor that regulates megakaryocytopoiesis and platelet production through binding to its receptor, Mpl, encoded by the c-mpl proto-oncogene. Circulating levels of TPO are regulated by receptor-mediated uptake and degradation. To better understand this mode of TPO regulat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cohen-Solal K,Vitrat N,Titeux M,Vainchenker W,Wendling F

    更新日期:1999-05-01 00:00:00

  • Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.

    abstract::Posttransplantation lymphoproliferative disease (PTLD) associated with Epstein-Barr virus (EBV) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation. PTLD is efficiently prevented by adoptive transfer of EBV-specific T cells from the donor. To make EBV-specific T cells available ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2009-08-236356

    authors: Moosmann A,Bigalke I,Tischer J,Schirrmann L,Kasten J,Tippmer S,Leeping M,Prevalsek D,Jaeger G,Ledderose G,Mautner J,Hammerschmidt W,Schendel DJ,Kolb HJ

    更新日期:2010-04-08 00:00:00

  • Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequences.

    abstract::Plasmin exposure modulates platelet aggregation responses, but a direct effect of plasmin on the platelet fibrinogen receptor, glycoprotein IIb/IIIa (GPIIb/IIIa), has never been conclusively shown in a plasma milieu. To examine this issue, we incubated platelets in platelet-rich plasma with plasmin and measured the ef...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pasche B,Ouimet H,Francis S,Loscalzo J

    更新日期:1994-01-15 00:00:00

  • Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.

    abstract::We treated 109 patients with adult acute lymphoblastic leukemia (ALL) diagnosed by histochemical and immunologic techniques. Patients were excluded only for age greater than 50 years and Burkitt's leukemia. Treatment included a four-drug remission induction phase followed by alternating cycles of noncrossresistant che...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Linker CA,Levitt LJ,O'Donnell M,Forman SJ,Ries CA

    更新日期:1991-12-01 00:00:00

  • Phorbol ester induces expression and function of interleukin-2 receptors on a human leukemic cell line with a T-cell precursor phenotype.

    abstract::We show here that a human leukemic cell line, PER-117, bearing the markers of a T-cell precursor phenotype, can be induced to express receptors for interleukin-2 (IL-2). These IL-2 receptors could be demonstrated to mediate a physiologic response to the lymphokine for which the high-affinity form of the IL-2 receptor ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kees UR

    更新日期:1988-11-01 00:00:00

  • Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia.

    abstract::Human T-cell leukemia virus type-I (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL), an aggressive lymphoproliferative disease. MicroRNAs (miRNAs) are differentially expressed during hematopoiesis and lineage commitment of hematopoietic stem cell progenitors (HSCPs). Here, we report aberrant expression o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-11-189845

    authors: Bellon M,Lepelletier Y,Hermine O,Nicot C

    更新日期:2009-05-14 00:00:00

  • Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy.

    abstract::Eighty-two patients with advanced multiple myeloma (MM) were enrolled in 2 sequential clinical studies of 1 or 2 courses of myeloablative therapy with stem cell support. Conditioning regimens consisted of high-dose melphalan (MEL) with or without total body irradiation (TX1 = 35) and MEL as the first preparative regim...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lemoli RM,Martinelli G,Zamagni E,Motta MR,Rizzi S,Terragna C,Rondelli R,Ronconi S,Curti A,Bonifazi F,Tura S,Cavo M

    更新日期:2000-04-01 00:00:00

  • Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21(WAF1).

    abstract::All-trans retinoic acid (ATRA) has previously been shown to inhibit the growth of OPM-2 human myeloma cells. The growth inhibition was postulated to result from a transcriptional downregulation of interleukin-6 receptor alpha (IL-6Ralpha) with IL-6Rbeta (gp130) unaffected. To formally test this hypothesis, an expressi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chen YH,Lavelle D,DeSimone J,Uddin S,Platanias LC,Hankewych M

    更新日期:1999-07-01 00:00:00

  • Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress.

    abstract::The interaction between platelet receptor glycoprotein Ibα and the A1 domain of von Willebrand factor (VWF) mediates tethering/translocation of platelets to sites of vascular injury. Unexpectedly, we observed platelets translocating over A1A2A3 domains protein slower than on A1 domain at high shear stress. This observ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-530428

    authors: Da Q,Behymer M,Correa JI,Vijayan KV,Cruz MA

    更新日期:2014-04-24 00:00:00

  • Accelerated cell-cycling of hematopoietic progenitor cells by growth factors.

    abstract::Recent advances in molecular biology have led to the identification of hematopoietic growth factors that support and influence the proliferation of hematopoietic progenitor cells in vitro and in vivo. Although these factors have been extensively studied, little is known of their role in the regulation of cell-cycling ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tanaka R,Katayama N,Ohishi K,Mahmud N,Itoh R,Tanaka Y,Komada Y,Minami N,Sakurai M,Shirakawa S

    更新日期:1995-07-01 00:00:00

  • Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis.

    abstract::Therapy for childhood acute lymphoblastic leukemia (ALL) is associated with 5-year survival rates of ∼90% even after largely eliminating cranial radiation. This meta-analysis assesses the long-term neurocognitive functioning after chemotherapy-only regimens among survivors of childhood ALL. We conducted a systematic r...

    journal_title:Blood

    pub_type: 杂志文章,meta分析,评审

    doi:10.1182/blood-2015-02-627414

    authors: Iyer NS,Balsamo LM,Bracken MB,Kadan-Lottick NS

    更新日期:2015-07-16 00:00:00

  • The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

    abstract::The functions of the alphaC domains of fibrinogen in clotting and fibrinolysis, which have long been enigmatic, were determined using recombinant fibrinogen truncated at Aalpha chain residue 251. Scanning electron microscopy and confocal microscopy revealed that the fibers of alpha251 clots were thinner and denser, wi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-2150

    authors: Collet JP,Moen JL,Veklich YI,Gorkun OV,Lord ST,Montalescot G,Weisel JW

    更新日期:2005-12-01 00:00:00

  • Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates.

    abstract::To test the in vivo cooperativity between interleukin-3 (IL-3) and erythropoietin (Epo) in stimulating erythropoiesis and hemoglobin F (HbF) production in primates, we administered recombinant human IL-3 and recombinant human Epo to baboons and macaques. The effect of these treatments was assessed by serial bone marro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Umemura T,al-Khatti A,Donahue RE,Papayannopoulou T,Stamatoyannopoulos G

    更新日期:1989-10-01 00:00:00

  • Identification and characterization of a differentiation antigen in human neutrophils and monocytes.

    abstract::Human promyelocytic leukemia (HL-60) cells were induced to differentiate into macrophage-like cells by treatment with 10(-7) mol/L 1,25-dihydroxyvitamin D3 (VD3). A monoclonal antibody (MoAb, 60B8), reactive with the particulate of the differentiated cells but not of the untreated cells, was isolated. The antigen reco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nozawa R,Kato H,Ito T,Yokota T

    更新日期:1988-05-01 00:00:00

  • Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.

    abstract::This 2-part, double-blind, placebo-controlled study was conducted to determine the safety and efficacy of etoricoxib, a COX-2 selective inhibitor, for the treatment of hemophilic arthropathy. In part 1 (6 weeks), 102 patients (> or = 12 years old) with hemophilic arthropathy were randomized to receive 90 mg etoricoxib...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2004-09-3501

    authors: Tsoukas C,Eyster ME,Shingo S,Mukhopadhyay S,Giallella KM,Curtis SP,Reicin AS,Melian A

    更新日期:2006-03-01 00:00:00

  • Mapping of genes that control the antibody response to human factor IX in mice.

    abstract::We tested the hypothesis that the antibody response to human factor IX in mice is controlled by genetic factors, especially histocompatibility antigens. Seven inbred mouse strains were immunized against human factor IX by adenoviral gene transfer or serial injections of human factor IX protein. A/J mice had the highes...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1126

    authors: Lozier JN,Tayebi N,Zhang P

    更新日期:2005-02-01 00:00:00

  • Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.

    abstract::Patients with severe aplastic anemia (SAA) and a neutrophil (PMN) count of less than 0.5 x 10(9)/L are exposed to a high risk of early mortality when treated with antilymphocyte globulin (ALG) and steroids, with the major problem being infectious complications. The addition of human recombinant granulocyte colony-stim...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Bacigalupo A,Broccia G,Corda G,Arcese W,Carotenuto M,Gallamini A,Locatelli F,Mori PG,Saracco P,Todeschini G

    更新日期:1995-03-01 00:00:00